Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG.L Regulatory News (MIG)

  • There is currently no data for MIG

Interim Management Statement - 3rd Quarter

13 Feb 2019 13:55

RNS Number : 9292P
Mobeus Income & Growth 2 VCT PLC
13 February 2019
 

 

Mobeus Income & Growth 2 VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2018

 

Mobeus Income & Growth 2 VCT plc presents an Interim Management Statement for the quarter ended 31 December 2018. The statement also includes relevant financial information between the end of the quarter and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 31 December 2018

At 30 September 2018

Net assets attributable to shareholders

£49,505,946

£48,860,422

Shares in issue

49,184,909

49,304,159

Net asset value (NAV) per share

100.65 pence

99.10 pence

Cumulative dividends paid to date per share since inception

78.00 pence

78.00 pence

Total return per share since inception (NAV basis)

178.65 pence

177.10 pence

 

DIVIDENDS

 

No dividends were paid during the quarter.

 

The Board has today declared an interim dividend of 5.00 pence per share for the year ending 31 March 2019, which will be paid on 22 March 2019 to shareholders on the share register on 22 February 2019. Following payment of this dividend, cumulative dividends paid per share since the launch of the current share class will be 83.00 pence per share.

 

SHARE BUY-BACKS

 

On 14 December 2018, the Company bought back 119,250 of its ordinary shares at a price of 88.00 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

INVESTMENT ACTIVITY

 

New investment

On 28 November 2018, the Company made a new investment of £0.28 million into Kudos Innovations Limited (trading as Grow Kudos), a platform for the dissemination of academic research.

 

Follow-on investments

On 9 October 2018, a follow-on investment of £0.54 million was made into Pattern Analytics Limited (trading as Biosite).

 

On 10 October 2018, a follow-on investment of £0.29 million was made into Proactive Group Holdings Inc.

 

On 19 October 2018 and 19 December 2018, follow-on investments totalling £0.09 million were made into MPB Group Limited.

 

Repurchase of preference shares by investee company

On 31 October 2018, The Plastic Surgeon Holdings Limited carried out a repurchase of preference shares in which £0.05 million of proceeds were received by the Company. After the quarter end, on 31 January 2019 a further £0.05 million of preference shares were repurchased by the company.

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the quarter and to the date of this announcement.

 

 

For further information, please contact:

Robert King, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCTJMJTMBABBML
Date   Source Headline
8th Sep 20213:00 pmRNSResult of AGM
8th Sep 20217:00 amRNSInterim Management Statement to 30 June 2021
12th Jul 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20217:00 amRNSAnnual Financial Report
6th Apr 20219:00 amRNSPartial Realisation of Investment - MPB Group Ltd
31st Mar 20219:00 amRNSAdmission to AIM of Parsley Box Group plc
26th Mar 20219:00 amRNSINVESTEE COMPANY – INTENTION TO FLOAT
11th Mar 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Mar 20219:00 amRNSInterim Management Statement to 31 December 2020
25th Feb 20219:30 amRNSInvestee Company - Intention to Float
26th Jan 20213:00 pmRNSReplacement - Transaction in Own Shares
11th Jan 202112:00 pmRNSRealisation of Investment
17th Dec 202011:40 amRNSTransaction in Own Shares and Total Voting Rights
2nd Dec 20203:23 pmRNSInterim Report
29th Sep 20207:00 amRNSTransaction in Own Shares
9th Sep 20203:58 pmRNSIMPACT OF RECENT DISPOSALS UPON NET ASSET VALUE
9th Sep 202011:05 amRNSAGM Results
8th Sep 20203:30 pmRNSInterim Management Statement to 30 June 2020
7th Sep 20207:00 amRNSRealisation of Investment
17th Aug 20207:30 amRNSRealisation of Investment
10th Aug 20208:54 amRNSRevised AGM Arrangements
3rd Jul 20204:00 pmRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20207:00 amRNSAnnual Financial Report
14th May 20209:15 amRNSDividend Declaration
2nd Apr 20205:10 pmRNSIssue of Equity
30th Mar 202012:40 pmRNSPublication of Suppl.Prospcts
27th Mar 20207:00 amRNSNet Asset Value(s)
23rd Mar 202011:30 amRNSTransaction in Own Shares
2nd Mar 202010:23 amRNSInterim Management Statement to 31 December 2019
28th Feb 20201:09 pmRNSFundraising Update
26th Feb 20202:48 pmRNSInterim Dividend
25th Feb 20203:15 pmRNSPublication of Suppl.Prospcts
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
7th Feb 20206:40 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:37 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:36 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:34 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:30 pmRNSPublication of Suppl.Prospcts
6th Feb 20203:45 pmRNSOffer Increase
3rd Feb 202011:30 amRNSTotal Voting Rights
13th Jan 202011:00 amRNSFundraising Update
8th Jan 20204:20 pmRNSIssue of Equity & Total Voting Rights
20th Dec 20193:00 pmRNSFundraising Update
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.